LNTH vs. RIOT, NEOG, QDEL, CLDX, NTLA, MYGN, OGN, BBIO, GKOS, and IONS
Should you be buying Lantheus stock or one of its competitors? The main competitors of Lantheus include Riot Platforms (RIOT), Neogen (NEOG), QuidelOrtho (QDEL), Celldex Therapeutics (CLDX), Intellia Therapeutics (NTLA), Myriad Genetics (MYGN), Organon & Co. (OGN), BridgeBio Pharma (BBIO), Glaukos (GKOS), and Ionis Pharmaceuticals (IONS).
Lantheus (NASDAQ:LNTH) and Riot Platforms (NASDAQ:RIOT) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, community ranking, profitability, valuation, risk, earnings, media sentiment and dividends.
Lantheus has a beta of 0.52, suggesting that its share price is 48% less volatile than the S&P 500. Comparatively, Riot Platforms has a beta of 4.19, suggesting that its share price is 319% more volatile than the S&P 500.
Lantheus has higher revenue and earnings than Riot Platforms. Lantheus is trading at a lower price-to-earnings ratio than Riot Platforms, indicating that it is currently the more affordable of the two stocks.
Riot Platforms has a net margin of 76.02% compared to Lantheus' net margin of 33.72%. Lantheus' return on equity of 54.10% beat Riot Platforms' return on equity.
Lantheus currently has a consensus price target of $99.17, indicating a potential upside of 25.45%. Riot Platforms has a consensus price target of $18.33, indicating a potential upside of 72.74%. Given Riot Platforms' stronger consensus rating and higher possible upside, analysts plainly believe Riot Platforms is more favorable than Lantheus.
Riot Platforms received 169 more outperform votes than Lantheus when rated by MarketBeat users. Likewise, 67.34% of users gave Riot Platforms an outperform vote while only 65.21% of users gave Lantheus an outperform vote.
In the previous week, Riot Platforms had 5 more articles in the media than Lantheus. MarketBeat recorded 14 mentions for Riot Platforms and 9 mentions for Lantheus. Lantheus' average media sentiment score of 1.45 beat Riot Platforms' score of -0.29 indicating that Lantheus is being referred to more favorably in the media.
99.1% of Lantheus shares are held by institutional investors. Comparatively, 40.3% of Riot Platforms shares are held by institutional investors. 2.1% of Lantheus shares are held by insiders. Comparatively, 4.4% of Riot Platforms shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Summary
Riot Platforms beats Lantheus on 11 of the 18 factors compared between the two stocks.
Get Lantheus News Delivered to You Automatically
Sign up to receive the latest news and ratings for LNTH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LNTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Lantheus Competitors List
Related Companies and Tools
